Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan K Percy

Showing results (61-70 of 107) with videos related to

Pageof 11
Sort By:
Journal of Autism and Developmental Disorders|January 30, 2017
Assessment of Caregiver Inventory for Rett SyndromeJane B Lane, Amber R Salter, Nancy E Jones, et al.
Neurology|March 29, 2019
Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndromeDaniel G Glaze, Jeffrey L Neul, Walter E Kaufmann, et al.
Nature Medicine|June 8, 2023
Trofinetide for the treatment of Rett syndrome: a randomized phase 3 studyJeffrey L Neul, Alan K Percy, Timothy A Benke, et al.
Brain & Development|September 16, 2018
Behavioral profiles in Rett syndrome: Data from the natural history studyCaroline B Buchanan, Jennifer L Stallworth, Alexandra E Scott, et al.
Pediatric Neurology|January 17, 2024
Trofinetide Treatment Demonstrates a Benefit Over Placebo for the Ability to Communicate in Rett SyndromeJeffrey L Neul, Alan K Percy, Timothy A Benke, et al.
American Journal of Medical Genetics. Part A|June 14, 2025
Medical Biases and Misconceptions Impact Diagnoses in Males With Loss of Function MECP2 VariantsTalia Thompson, Dennis Gurfinkel, Lori Silveira, et al.
Pediatric Neurology|October 7, 2014
Pubertal development in Rett syndrome deviates from typical femalesJohn T Killian, Jane B Lane, Gary R Cutter, et al.
Med (New York, N.Y.)|July 18, 2024
Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results of the 32-month, open-label LILAC-2 studyAlan K Percy, Jeffrey L Neul, Timothy A Benke, et al.
Journal of Child Neurology|February 20, 2009
A study of the treatment of Rett syndrome with folate and betaineDaniel G Glaze, Alan K Percy, Kathleen J Motil, et al.
Frontiers in Pharmacology|February 6, 2024
Development of trofinetide for the treatment of Rett syndrome: from bench to bedsideMelissa Kennedy, Larry Glass, Daniel G Glaze, et al.
Pageof 11

Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Journal of Autism and Developmental Disorders|January 30, 2017
Assessment of Caregiver Inventory for Rett SyndromeJane B Lane, Amber R Salter, Nancy E Jones, et al.
Neurology|March 29, 2019
Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndromeDaniel G Glaze, Jeffrey L Neul, Walter E Kaufmann, et al.
Nature Medicine|June 8, 2023
Trofinetide for the treatment of Rett syndrome: a randomized phase 3 studyJeffrey L Neul, Alan K Percy, Timothy A Benke, et al.
Brain & Development|September 16, 2018
Behavioral profiles in Rett syndrome: Data from the natural history studyCaroline B Buchanan, Jennifer L Stallworth, Alexandra E Scott, et al.
Pediatric Neurology|January 17, 2024
Trofinetide Treatment Demonstrates a Benefit Over Placebo for the Ability to Communicate in Rett SyndromeJeffrey L Neul, Alan K Percy, Timothy A Benke, et al.
American Journal of Medical Genetics. Part A|June 14, 2025
Medical Biases and Misconceptions Impact Diagnoses in Males With Loss of Function MECP2 VariantsTalia Thompson, Dennis Gurfinkel, Lori Silveira, et al.
Pediatric Neurology|October 7, 2014
Pubertal development in Rett syndrome deviates from typical femalesJohn T Killian, Jane B Lane, Gary R Cutter, et al.
Med (New York, N.Y.)|July 18, 2024
Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results of the 32-month, open-label LILAC-2 studyAlan K Percy, Jeffrey L Neul, Timothy A Benke, et al.
Journal of Child Neurology|February 20, 2009
A study of the treatment of Rett syndrome with folate and betaineDaniel G Glaze, Alan K Percy, Kathleen J Motil, et al.
Frontiers in Pharmacology|February 6, 2024
Development of trofinetide for the treatment of Rett syndrome: from bench to bedsideMelissa Kennedy, Larry Glass, Daniel G Glaze, et al.
Pageof 11